Cabell Christopher (CIK 1814928) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-24). Recent activity: Sell IKT (338,282 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-24 | Inhibikase Therapeutics, Inc. (IKT) | President & Head of R&D | Sell | 338,282 | $0 |
Source: SEC Form 4 filings · as of 2026-02-24